Targeting the gut-liver-immune axis to treat cirrhosis
Year: 2020
Type: review
Source: Gut
Institutions: King's College London, University of California San Diego
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: Restoring innate immunity in cirrhosis with faecal microbial transplantation, A PROspective double-blind placebo-controlled multicentre trial of faecal MIcrobiota tranSplantation to improve outcomEs in patients with cirrhosis - PROMISE trial., PROFIT Trial: A PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis
OpenAlex ID: W3092959702
